Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 75 entries
View as:

A Study to Assess the Pharmacokinetics of the Hydrocodone Extended-Release Tablet (CEP-33237) in Subjects With Normal Renal Function and Subjects With Varying Degrees of Renal Impairment

Phase: N/A Priority: Normal
NCT ID: NCT01319266 Org: User:
Start: 03/31/11 End: 10/31/11 Due: 10/31/12

Dose-Finding Study to Evaluate the Efficacy and Safety of Modafinil as Treatment for Adults With ADHD

Phase: N/A Priority: Normal
NCT ID: NCT00315276 Org: User:
Start: 05/31/06 End: 01/31/07 Due: 01/31/08

Safety and Efficacy of Treanda™ (Bendamustine HCl) in Patients With Indolent Non-Hodgkin's Lymphoma (NHL) Who Are Refractory to Rituximab

Phase: N/A Priority: Normal
NCT ID: NCT00139841 Org: User:
Start: 10/31/05 End: 10/31/09 Due: 10/31/10

A Study to Evaluate the Pharmacokinetics of the Hydrocodone Extended-Release Tablet (CEP-33237) in Subjects With Normal Hepatic Function and Subjects With Moderate Hepatic Impairment

Phase: N/A Priority: Normal
NCT ID: NCT01319279 Org: User:
Start: 04/30/11 End: 08/31/11 Due: 08/31/12

Safety and Efficacy Study of CEP-1347 in the Treatment of Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00040404 Org: User:
Start: 03/31/02 End: 08/31/05 Due: 08/31/06

A 10-Week Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00236015 Org: User:
Start: 11/30/04 End: 03/31/06 Due: 03/31/07

Evaluating the Safety and Tolerability of OraVescent Fentanyl for Opioid Tolerant Patients With Noncancer Related Breakthrough Pain

Phase: N/A Priority: Normal
NCT ID: NCT00228605 Org: User:
Start: 03/31/05 End: 05/31/07 Due: 05/31/08

Efficacy and Safety of Obatoclax Mesylate in Combination With Carboplatin and Etoposide Compared With Carboplatin and Etoposide Alone in Chemotherapy-Naive Patients With Extensive-Stage Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01563601 Org: User:
Start: 08/31/12 End: 01/31/18 Due: 01/31/19

Pharmacokinetics of Bendamustine Hydrochloride in Patients With Relapsed or Refractory Malignancy

Phase: N/A Priority: Normal
NCT ID: NCT00863850 Org: User:
Start: 05/31/09 End: 03/31/10 Due: 03/31/11

Study of Breakthrough Cancer Pain: Assessment of Fentanyl Buccal Tablets Titration and Treatment in Opioid-Tolerant Patients

Phase: N/A Priority: Normal
NCT ID: NCT00842829 Org: User:
Start: 01/31/09 End: 05/31/11 Due: 05/31/12

Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for Management of Breakthrough Pain

Phase: N/A Priority: Normal
NCT ID: NCT00214942 Org: User:
Start: 09/30/05 End: - Due: -

Safety and Efficacy Study of Armodafinil (CEP-10953) in the Treatment of Excessive Sleepiness Associated With Narcolepsy

Phase: N/A Priority: Normal
NCT ID: NCT00078377 Org: User:
Start: 03/31/04 End: 01/31/05 Due: 01/31/06

OraVescent Fentanyl (OVF) for the Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00105937 Org: User:
Start: 04/30/04 End: 11/30/06 Due: 11/30/07

Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents

Phase: N/A Priority: Normal
NCT ID: NCT00825227 Org: User:
Start: 12/31/08 End: 02/28/10 Due: 02/28/11

Study of PROVIGIL ® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy

Phase: N/A Priority: Normal
NCT ID: NCT00107796 Org: User:
Start: 10/31/04 End: 09/30/05 Due: 09/30/06

Extension Study of ACTIQ Treatment for Children and Adolescents With Breakthrough Pain

Phase: N/A Priority: Normal
NCT ID: NCT00236093 Org: User:
Start: 10/31/06 End: - Due: -

Evaluate the Efficacy and Safety of ACTIQ in Patients With Cancer and Breakthrough Pain

Phase: N/A Priority: Normal
NCT ID: NCT00236145 Org: User:
Start: 06/30/04 End: - Due: -

Study of CEP-701 in Treatment of Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00081601 Org: User:
Start: 03/31/04 End: 06/30/05 Due: 06/30/06

Study of the Effect of Armodafinil Treatment in Healthy Subjects With Excessive Sleepiness Associated With Jet Lag Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00758498 Org: User:
Start: 09/30/08 End: 02/28/09 Due: 02/28/10

Study of CEP-701 (Lestaurtinib) in Patients With Acute Myeloid Leukemia (AML)

Phase: N/A Priority: Normal
NCT ID: NCT00079482 Org: User:
Start: 10/31/03 End: 01/31/10 Due: 01/31/11

Evaluate the Safety of GABITRIL in Adults With Generalized Anxiety Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00233675 Org: User:
Start: 08/31/03 End: - Due: -

Study to Determine the Maximum Tolerated Dose and Evaluate the Efficacy and Safety of CEP-18770 (Delanzomib) in Patients With Relapsed Multiple Myeloma Refractory to the Most Recent Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01023880 Org: User:
Start: 01/31/10 End: 01/31/13 Due: 01/31/14

A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01072929 Org: User:
Start: 01/31/10 End: 03/31/12 Due: 03/31/13

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01072630 Org: User:
Start: 03/31/10 End: 11/30/12 Due: 11/30/13

Fentanyl Buccal Tablets Versus Immediate Release Oxycodone for Breakthrough Pain in Patients With Chronic Pain

Phase: N/A Priority: Normal
NCT ID: NCT00813488 Org: User:
Start: 12/31/08 End: 01/31/10 Due: 01/31/11